Research Topic · Peer-Reviewed

Radioligand Binding Assay

A Radioligand Binding Assay is an experimental technique used to measure and study the affinity of a molecule to a specific binding partner. It is used to measure the binding of molecules to receptor proteins and enzymes, and is used to screen for potential drugs that interact along specific pathways. The assay prov…

📚 0 peer-reviewed articles cited 🔖 ISSN 2766-8630 🗓 Reviewed July 2026

Overview

A Radioligand Binding Assay is an experimental technique used to measure and study the affinity of a molecule to a specific binding partner. It is used to measure the binding of molecules to receptor proteins and enzymes, and is used to screen for potential drugs that interact along specific pathways. The assay provides important insights into drug action and target specificity, facilitating drug development and clinical research. The assay is also used to study receptor-mediated gene transcription, in vivo receptor binding, and receptor-mediated signal transduction pathways. Radioligand Binding Assay is a very important tool for drug development, as it can accurately measure drug-receptor interactions and provide data for the development and design of more effective and safe drugs.

Research published in this journal

No peer-reviewed research on this exact topic has been published in Radiation and Nuclear Medicine yet. Browse the journal →

Editorial oversight

Curated from peer-reviewed research published in Radiation and Nuclear Medicine (ISSN 2766-8630).

Journal editorial board
Suliman Salih · United Arab Emirates Ciro Gabriele Mainolfi · Italy Ryuya Yamanaka · Japan

This page summarises published research for orientation; it is not medical or professional advice.